GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

MXCT · Dec 31, 2023

MAXCYTE, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001558370-24-003001General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

18.98% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-111.23% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

62.72% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

187.44% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-247.73% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

122.16% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

71.70% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesHistory building

Jun 30, 20230/7 normalizedLevel 3 Sep 30, 20230/7 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/8 normalizedLevel 3 Sep 30, 20240/8 normalizedLevel 3 Dec 31, 20240/8 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20257/8 normalizedLevel 3 Sep 30, 20257/8 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20268/8 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 17.31%
Current: 18.98%
Delta: 1.67%

Cash Generation Increased

Previous: -198.02%
Current: -111.23%
Delta: 86.79%

Inventory Pressure Decreased

Previous: 301.25%
Current: 62.72%
Delta: -238.53%

Margin Increased

Previous: 173.33%
Current: 187.44%
Delta: 14.11%

Profitability Increased

Previous: -335.38%
Current: -247.73%
Delta: 87.65%

R And D Intensity Decreased

Previous: 150.57%
Current: 122.16%
Delta: -28.41%

Sbc Intensity Decreased

Previous: 86.74%
Current: 71.70%
Delta: -15.05%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · MXCT Fundamental State →Has State · MAXCYTE, INC. →Transitioned To · MXCT Fundamental State →Transitioned To · MXCT CAPEX_INTENSITY_INCREASED →Transitioned To · MXCT CASH_GENERATION_INCREASED →Transitioned To · MXCT INVENTORY_PRESSURE_DECREASED →Transitioned To · MXCT MARGIN_INCREASED →Transitioned To · MXCT PROFITABILITY_INCREASED →Transitioned To · MXCT R_AND_D_INTENSITY_DECREASED →Transitioned To · MXCT SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.